A direct radioimmunoassay for the determination of ACTH in a small volume of serum was developed using a commercially available antiserum and tracer. A single-stage radioimmunoassay with an incubation period of 4 days gave reliable and reproducible ACTH values. In the incubation medium 0·1% 2-mercaptoethanol was used as the antioxidant. During a 15-month period the assay has been used routinely in the laboratory.
The coefficient of variation was less than 10% in the physiological and pathological range. A normal range of 12 to 60 ng/L was found. The reliability of the assay is demonstrated by results obtained in patients with disorders of the pituitary-adrenal axis.
References
1.
OrthDN. Adrenocorticotropic hormone (ACTH). In: JaffeBMBehrmanHR. Methods of Hormone Radioimmunoassay. New York: Academic Press, 1979; 245–84.
2.
GoverdeHJM. Bioactive versus immunoreactive adrenocorticotrophin in human blood. Thesis 1981; University of Nijmegen, Nijmegen. The Netherlands.
3.
BersonSAYalowRS. Radioimmunoassay of ACTH in plasma. J Clin Invest1968; 47: 2725–51.
4.
HoganPReesLHLowryPJStudies on the stability of human adrenocorticotrophin in blood and plasma. J Endocrinol1976; 71: 63–4.
5.
NicholsonWEDavisDRSherrcllBJRapid radioimmunoassay for corticotrophin in unextracted human plasma. Clin Chem1984; 30/2: 259–65.
6.
CrapoL.Cushing's syndrome: A review of diagnostic tests. Metabolism1979; 28: 955–77.
7.
CroughsRJM. Use of lysine-vasopressin in the differential diagnosis of Cushing's syndrome. Acta Endocrinol (Copenh)1970; 65: 595–607.
8.
CroughsRJMDocterRDe JongFH. Comparison of oral and intravenous dexamethasone suppression tests in the differential diagnosis of Cushing's syndrome. Acta Endocrinol (Copenh)1973; 72: 54–62.
9.
NelsonDHMeakinJWDealyJBACTH producing tumor of the pituitarv gland. N Engl J Med1958; 259: 161–4.
10.
CohenKLNothRHPeckinskiT.Incidence of pituitary tumours following adrenalectomy. Arch Intern Med1978; 138: 575–9.
11.
JonesMTGillhamBBeckfordU.Effect of treatment with sodium valproate and diazepam on plasma corticotrophin in Nelson's syndrome. Lancet1981; 1: 1179–81.
12.
EliasANGwinupGValentaLJ. Effects of valproic acid, naloxone and hydrocortisone in Nelson's syndrome and Cushing's disease. Clin Endocrinol (Oxf)1981; 15: 151–4.
13.
KoppeschaarHPFCroughsRJMThijssenJHHSodium valproate and heterogeneity of pituitary dependent Cushing's syndrome. Lancet1982; 21: 1253.
14.
BöhmNLippman-GrobPetrykowskiW.Familial Cushing's syndrome due to pigmented multinodular adrenocortical dysplasia. Acta Endocrinol (Copenh). 1983; 102: 428–35.
15.
LandonJGreenwoodFC. Homologous radioimmunoassay for plasma levels of corticotrophin in man. Lancet1968; 7537: 273–6.
16.
FangVSTricouBJRobertsonAPlasma ACTH and Cortisol levels in depressed patients: Relation to dexamethasone suppression test. Life Sci1981; 29: 931–8.
17.
Kasperlik-ZaluskaAANielubowiczJWislawskiJ.Nelson's syndrome: Incidence and prognosis. Clin Endocrinol1983; 19: 693–8.
18.
PietersGFFMHermusARMMSmalsAGHResponsiveness of the hypophyseal-adrenocortical axis to corticotrophin-releasing factor in pituitary-dependent Cushing's disease. J Clin Endocrinol Metab1983; 3: 513–16.
19.
GrossmanAPerryLSchallyAVNew hypothalamic hormone, corticotropin-releasing factor, specifically stimulates the release of adrenocorticotropic hormone and Cortisol in man. Lancet1982; 8278: 921–2.
20.
OrthDNJacksonRVDecherneyGSEffect of synthetic ovine corticotropin-releasing factor: Dose response of plasma adrenocorticotropin and Cortisol. J Clin Invest1983; 71: 587–95.
21.
ThijssenJHHvan den BergJHMAdlercreutzHThe determination of Cortisol in human plasma: Evaluation and comparison of seven assays. Clin Chim Acta1980; 100: 39–46.
